{"id":"https://openalex.org/W3203222544","doi":"https://doi.org/10.1111/jnc.15521","title":"The metabolite GLP\u20101 (9\u201036) is neuroprotective and anti\u2010inflammatory in cellular models of neurodegeneration","display_name":"The metabolite GLP\u20101 (9\u201036) is neuroprotective and anti\u2010inflammatory in cellular models of neurodegeneration","publication_year":2021,"publication_date":"2021-09-27","ids":{"openalex":"https://openalex.org/W3203222544","doi":"https://doi.org/10.1111/jnc.15521","mag":"3203222544","pmid":"https://pubmed.ncbi.nlm.nih.gov/34569615","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8627453"},"language":"en","primary_location":{"id":"doi:10.1111/jnc.15521","doi":"https://doi.org/10.1111/jnc.15521","is_oa":false,"landing_page_url":"https://doi.org/10.1111/jnc.15521","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8627453","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100669061","display_name":"Yazhou Li","orcid":"https://orcid.org/0000-0002-6048-3660","observed_orcids":["https://orcid.org/0000-0002-6048-3660"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210136897","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Yazhou Li","raw_affiliation_strings":["Drug Design & Development Section Translational Gerontology Branch Intramural Research Program National Institute on Aging National Institutes of Health  Baltimore Maryland USA","Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA"],"raw_orcid":"https://orcid.org/0000-0002-6048-3660","affiliations":[{"raw_affiliation_string":"Drug Design & Development Section Translational Gerontology Branch Intramural Research Program National Institute on Aging National Institutes of Health  Baltimore Maryland USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210136897"]},{"raw_affiliation_string":"Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012561586","display_name":"Elliot J. Glotfelty","orcid":"https://orcid.org/0000-0001-5125-8720","observed_orcids":["https://orcid.org/0000-0001-5125-8720"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I4210136897","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}],"countries":["SE","US"],"is_corresponding":false,"raw_author_name":"Elliot J. Glotfelty","raw_affiliation_strings":["Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden","Drug Design & Development Section Translational Gerontology Branch Intramural Research Program National Institute on Aging National Institutes of Health  Baltimore Maryland USA","Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA"],"raw_orcid":"https://orcid.org/0000-0001-5125-8720","affiliations":[{"raw_affiliation_string":"Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]},{"raw_affiliation_string":"Drug Design & Development Section Translational Gerontology Branch Intramural Research Program National Institute on Aging National Institutes of Health  Baltimore Maryland USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210136897"]},{"raw_affiliation_string":"Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041738376","display_name":"Tobias E. Karlsson","orcid":"https://orcid.org/0000-0002-9919-3353","observed_orcids":["https://orcid.org/0000-0002-9919-3353"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Tobias Karlsson","raw_affiliation_strings":["Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden"],"raw_orcid":"https://orcid.org/0000-0002-9919-3353","affiliations":[{"raw_affiliation_string":"Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051586809","display_name":"Lowella V. Fortuno","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lowella V. Fortuno","raw_affiliation_strings":["Molecular Mechanisms of Cellular Stress and Inflammation Unit, Integrative Neuroscience Department, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Mechanisms of Cellular Stress and Inflammation Unit, Integrative Neuroscience Department, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108880617","display_name":"Brandon K. Harvey","orcid":"https://orcid.org/0000-0002-4036-1383","observed_orcids":["https://orcid.org/0000-0002-4036-1383","https://orcid.org/0000-0002-7471-9937"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brandon K. Harvey","raw_affiliation_strings":["Molecular Mechanisms of Cellular Stress and Inflammation Unit, Integrative Neuroscience Department, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland, USA"],"raw_orcid":"https://orcid.org/0000-0002-4036-1383","affiliations":[{"raw_affiliation_string":"Molecular Mechanisms of Cellular Stress and Inflammation Unit, Integrative Neuroscience Department, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056649584","display_name":"Nigel H. Greig","orcid":"https://orcid.org/0000-0002-3032-1468","observed_orcids":["https://orcid.org/0000-0002-3032-1468"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210136897","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Nigel H. Greig","raw_affiliation_strings":["Drug Design & Development Section Translational Gerontology Branch Intramural Research Program National Institute on Aging National Institutes of Health  Baltimore Maryland USA","Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA"],"raw_orcid":"https://orcid.org/0000-0002-3032-1468","affiliations":[{"raw_affiliation_string":"Drug Design & Development Section Translational Gerontology Branch Intramural Research Program National Institute on Aging National Institutes of Health  Baltimore Maryland USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210136897"]},{"raw_affiliation_string":"Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5056649584","https://openalex.org/A5100669061"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210136897"],"apc_list":{"value":3950,"currency":"USD","value_usd":3950},"apc_paid":null,"fwci":2.9932,"has_fulltext":false,"cited_by_count":47,"citation_normalized_percentile":{"value":0.92675493,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"159","issue":"5","first_page":"867","last_page":"886"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.3215000033378601,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.3215000033378601,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.2809999883174896,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.15610000491142273,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.8690000176429749},{"id":"https://openalex.org/keywords/glp-1-receptor","display_name":"GLP-1 receptor","score":0.9779999852180481},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9950000047683716},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.9240000247955322},{"id":"https://openalex.org/keywords/neurodegeneration","display_name":"neurodegeneration","score":0.9829999804496765},{"id":"https://openalex.org/keywords/glutamate-excitotoxicity","display_name":"glutamate excitotoxicity","score":0.7839999794960022},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.9980000257492065},{"id":"https://openalex.org/keywords/camp-signaling","display_name":"cAMP signaling","score":0.8799999952316284},{"id":"https://openalex.org/keywords/protein-kinase-a","display_name":"protein kinase A","score":0.9919999837875366},{"id":"https://openalex.org/keywords/ampk","display_name":"AMPK","score":0.8790000081062317},{"id":"https://openalex.org/keywords/microglia","display_name":"microglia","score":0.9580000042915344},{"id":"https://openalex.org/keywords/lipopolysaccharide","display_name":"lipopolysaccharide","score":0.9850000143051147},{"id":"https://openalex.org/keywords/alpha-synuclein","display_name":"alpha-synuclein","score":0.8700000047683716},{"id":"https://openalex.org/keywords/amyloid-beta","display_name":"amyloid-beta","score":0.9679999947547913},{"id":"https://openalex.org/keywords/sh-sy5y-cells","display_name":"SH-SY5Y cells","score":0.800000011920929},{"id":"https://openalex.org/keywords/hmc3-cells","display_name":"HMC3 cells","score":0.8240000009536743},{"id":"https://openalex.org/keywords/neurotrophic-effects","display_name":"neurotrophic effects","score":0.7139999866485596}],"concepts":[{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.944225013256073},{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.8876535892486572},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.6444661617279053},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.5292574763298035},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.4767104983329773},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.384819358587265},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.374811053276062},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.326452374458313},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3028443455696106},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.146200031042099},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.12995457649230957},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.10278382897377014},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.08589926362037659}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002461","descriptor_name":"Cell Line, Transformed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011247","descriptor_name":"Pregnancy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017628","descriptor_name":"Microglia","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D017628","descriptor_name":"Microglia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D017628","descriptor_name":"Microglia","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018920","descriptor_name":"Coculture Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019636","descriptor_name":"Neurodegenerative Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D019636","descriptor_name":"Neurodegenerative Diseases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019636","descriptor_name":"Neurodegenerative Diseases","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/jnc.15521","doi":"https://doi.org/10.1111/jnc.15521","is_oa":false,"landing_page_url":"https://doi.org/10.1111/jnc.15521","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},{"id":"pmid:34569615","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34569615","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of neurochemistry","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8627453","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8627453","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Neurochem","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:8627453","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8627453","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Neurochem","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/2","display_name":"Zero hunger","score":0.4099999964237213}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000877303","display_name":"ALZHEIMERS RESEARCH PROJECT:  Neuroprotective role of GLP-1 receptor agonists (Neurodegenerative disorders & Alzheimer's disease)","funder_award_id":"ZIAAG000333","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337337","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":93,"referenced_works":["https://openalex.org/W863873638","https://openalex.org/W1507814807","https://openalex.org/W1525058897","https://openalex.org/W1535374793","https://openalex.org/W1546941007","https://openalex.org/W1583334338","https://openalex.org/W1963260622","https://openalex.org/W1963844828","https://openalex.org/W1969932276","https://openalex.org/W1970916794","https://openalex.org/W1971244959","https://openalex.org/W1975819463","https://openalex.org/W1979288606","https://openalex.org/W1979468130","https://openalex.org/W1981316849","https://openalex.org/W1985241513","https://openalex.org/W1985305554","https://openalex.org/W1994665422","https://openalex.org/W1998869094","https://openalex.org/W2004424892","https://openalex.org/W2004977380","https://openalex.org/W2014328130","https://openalex.org/W2024241633","https://openalex.org/W2025865178","https://openalex.org/W2030198351","https://openalex.org/W2032922774","https://openalex.org/W2043693375","https://openalex.org/W2053781227","https://openalex.org/W2061164005","https://openalex.org/W2061202826","https://openalex.org/W2065429430","https://openalex.org/W2071620927","https://openalex.org/W2080785707","https://openalex.org/W2097724095","https://openalex.org/W2106339546","https://openalex.org/W2106824929","https://openalex.org/W2107284289","https://openalex.org/W2107387649","https://openalex.org/W2111320266","https://openalex.org/W2116478518","https://openalex.org/W2128631317","https://openalex.org/W2130083450","https://openalex.org/W2130536805","https://openalex.org/W2145451941","https://openalex.org/W2146534889","https://openalex.org/W2151434892","https://openalex.org/W2152355721","https://openalex.org/W2168552871","https://openalex.org/W2270971263","https://openalex.org/W2281449070","https://openalex.org/W2294718904","https://openalex.org/W2339053935","https://openalex.org/W2342553225","https://openalex.org/W2477231886","https://openalex.org/W2521431100","https://openalex.org/W2536024417","https://openalex.org/W2549177900","https://openalex.org/W2566114442","https://openalex.org/W2572710398","https://openalex.org/W2609107212","https://openalex.org/W2744843428","https://openalex.org/W2748712819","https://openalex.org/W2765585831","https://openalex.org/W2770385888","https://openalex.org/W2790068096","https://openalex.org/W2794731784","https://openalex.org/W2807256450","https://openalex.org/W2856796550","https://openalex.org/W2889961434","https://openalex.org/W2900518009","https://openalex.org/W2900848270","https://openalex.org/W2908687677","https://openalex.org/W2911978674","https://openalex.org/W2914024845","https://openalex.org/W2940482405","https://openalex.org/W2943719474","https://openalex.org/W2970389738","https://openalex.org/W2972655539","https://openalex.org/W2974445899","https://openalex.org/W2979841702","https://openalex.org/W2986796592","https://openalex.org/W3000080966","https://openalex.org/W3012083507","https://openalex.org/W3014553064","https://openalex.org/W3019350328","https://openalex.org/W3025383706","https://openalex.org/W3036438870","https://openalex.org/W3048449568","https://openalex.org/W3086149804","https://openalex.org/W3088400563","https://openalex.org/W3089728969","https://openalex.org/W3100305783","https://openalex.org/W3103351591"],"related_works":["https://openalex.org/W1535374793","https://openalex.org/W7023972458","https://openalex.org/W2078613171","https://openalex.org/W4394305629","https://openalex.org/W2148456968","https://openalex.org/W4382133547","https://openalex.org/W7162114006","https://openalex.org/W7169865039","https://openalex.org/W2106339546","https://openalex.org/W4417506806"],"abstract_inverted_index":{"Glucagon-like":[0],"peptide-1":[1],"(GLP-1)":[2],"is":[3],"best":[4],"known":[5],"for":[6,44],"its":[7,239],"insulinotropic":[8],"action":[9],"following":[10],"food":[11],"intake.":[12],"Its":[13],"metabolite,":[14],"GLP-1":[15,24,42,54,82,104,148,158,190,215,231],"(9-36),":[16],"was":[17],"assumed":[18],"biologically":[19],"inactive":[20],"because":[21],"of":[22,39,81,125,147,179,189,214,230],"low":[23],"receptor":[25],"(GLP-1R)":[26],"affinity":[27],"and":[28,48,64,73,88,115,134,169,172,183,186,197,202,238],"non-insulinotropic":[29],"properties;":[30],"however,":[31],"recent":[32],"studies":[33,227],"contradict":[34],"this":[35],"assumption.":[36],"Increased":[37],"use":[38,59,124],"FDA":[40],"approved":[41],"analogues":[43],"treating":[45],"metabolic":[46],"disorders":[47],"neurodegenerative":[49],"diseases":[50],"raises":[51],"interest":[52],"in":[53,70,200,217,247],"(9-36)'s":[55,105,232],"biological":[56],"role.":[57],"We":[58,176],"human":[60],"SH-SY5Y":[61],"neuroblastoma":[62],"cells":[63],"a":[65,242],"GLP-1R":[66,130],"over-expressing":[67],"variety":[68],"(#9),":[69],"both":[71],"undifferentiated":[72],"differentiated":[74],"states,":[75],"to":[76,142,160],"evaluate":[77],"the":[78,94,123,144,235],"neurotrophic/neuroprotective":[79],"effects":[80,146,188,213,233],"(9-36)":[83,149,159,216],"against":[84,150],"toxic":[85],"glutamate":[86],"exposure":[87],"other":[89],"oxidative":[90],"stress":[91],"models":[92],"(via":[93,153],"MTS,":[95],"LDH":[96],"or":[97,129,167,224,244],"ROS":[98],"assays).":[99],"In":[100],"addition,":[101],"we":[102,156,208],"examine":[103],"signaling":[106],"pathways,":[107],"including":[108],"cyclic-adenosine":[109],"monophosphate":[110],"(cAMP),":[111],"protein":[112,119],"kinase-A":[113],"(PKA),":[114],"5'":[116],"adenosine":[117],"monophosphate-activated":[118],"kinase":[120],"(AMPK)":[121],"via":[122,174],"ELISA,":[126],"pharmacological":[127],"inhibitors,":[128],"antagonist.":[131],"Human":[132],"HMC3":[133,201],"mouse":[135],"IMG":[136,203],"microglial":[137,204],"cell":[138],"lines":[139],"were":[140],"used":[141],"study":[143],"anti-inflammatory":[145],"lipopolysaccharide":[151],"(LPS)":[152],"ELISA).":[154],"Finally,":[155],"applied":[157],"primary":[161,218,243],"dissociation":[162],"cultures":[163,220],"challenged":[164,221],"with":[165,222],"\u03b1-synuclein":[166,223],"amyloid-\u03b2":[168],"assessed":[170],"survival":[171],"morphology":[173],"immunochemistry.":[175],"demonstrate":[177],"evidence":[178],"GLP-1R,":[180],"cAMP,":[181],"PKA,":[182],"AMPK-mediated":[184],"neurotrophic":[185],"neuroprotective":[187],"(9-36).":[191],"The":[192],"metabolite":[193],"significantly":[194],"reduced":[195],"IL-6":[196],"TNF-\u03b1":[198],"levels":[199],"cells,":[205],"respectively.":[206],"Lastly,":[207],"show":[209],"mild":[210],"but":[211],"significant":[212],"neuron":[219],"amyloid-\u03b2.":[225],"These":[226],"enhance":[228],"understanding":[229],"on":[234],"nervous":[236],"system":[237],"potential":[240],"as":[241],"complementary":[245],"treatment":[246],"pathological":[248],"contexts.":[249]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":13},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":7}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-10-11T00:00:00"}